The University of Texas MD Anderson Cancer Center received a Project Grant award of $412,768 from the National Cancer Institute (CFDA 93.394 - Cancer Detection and Diagnosis Research) on September 19, 2023. This award will fund the development of an "ATTACHER" microfluidic device to streamline and improve the sensitivity and specificity of isolating antigen-specific T cells from cancer patient samples. The goal is to enable rapid, unbiased identification of T cells with anti-tumor potential, which could aid in the progress of cancer immunotherapies.
As part of this effort, Rice University will receive a sub-award to support 0.75 academic months of effort from Dr. Lillehoj to assist in developing and validating the microfluidic assay. The proposed work is expected to be completed by August 31, 2025.
Generated 7/16/24, 6:21 AM